Key result
A quantitative approach to loop diuretic usage primarily involving natriuresis is proposed to advance the understanding and care of dogs with congestive heart failure.
Why the study?
Diuretic dosing and efficacy in dogs with CHF are traditionally based on clinical signs rather than quantitative measures of drug action, whereas human CHF care increasingly uses natriuresis to guide therapy.
Does a quantitative approach to loop diuretic usage involving natriuresis improve the management of dogs with congestive heart failure?
Does a quantitative approach to loop diuretic usage involving natriuresis improve the management of dogs with congestive heart failure?
A quantitative approach to loop diuretic usage based on natriuresis may improve the understanding and management of congestive heart failure in dogs.
May warrant consideration of natriuresis-guided diuretic dosing in canine CHF; leaves open prospective trials for validation.
Diuretics, such as furosemide, are routinely administered to dogs with congestive heart failure (CHF). Traditionally, dose and determination of efficacy primarily are based on clinical signs rather than quantitative measures of drug action. Treatment of human CHF patients increasingly is guided by quantification of urine sodium concentration (uNa) and urine volume after diuretic administration. Use of these and other measures of diuretic responsiveness is associated with decreased duration of hospitalization, complication rates, future rehospitalization, and mortality. At their core, loop diuretics act through natriuresis, and attention to body sodium (Na) stores and handling offers insight into the pathophysiology of CHF and pharmacology of diuretics beyond what is achievable from clinical signs alone. Human patients with low diuretic responsiveness or diuretic resistance are at risk for difficult or incomplete decongestion that requires diuretic intensification or other remedial strategies. Identification of the specific etiology of resistance in a patient can help tailor personalized interventions. In this review, we advance the concept of loop diuretic responsiveness by highlighting Na and natriuresis. Specifically, we review body water homeostasis and congestion in light of the increasingly recognized role of interstitial Na, propose definitions for diuretic responsiveness and resistance in veterinary subjects, review relevant findings of recent studies, explain how the particular cause of resistance can guide treatment, and identify current knowledge gaps. We believe that a quantitative approach to loop diuretic usage primarily involving natriuresis will advance our understanding and care of dogs with CHF.
No takes yet. Share an insight, caveat, or question.
Oyama et al. (2022) conducted a review in Congestive heart failure. Loop diuretics (furosemide) was evaluated. A quantitative approach to loop diuretic usage primarily involving natriuresis is proposed to advance the understanding and care of dogs with congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: